EMERGENT BIOSOLUTIONS INC. (EBS) Total liabilities 2016–2025
EMERGENT BIOSOLUTIONS INC. (EBS) total liabilities at each fiscal year-end, per SEC filings.
$796.0MFY2025 · since FY2016: $373.9M → $796.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $796.0M | -12.2% |
| FY2024 | $906.9M | -22.7% |
| FY2023 | $1.2B | -34.0% |
| FY2022 | $1.8B | +32.1% |
| FY2021 | $1.3B | -6.3% |
| FY2020 | $1.4B | +15.9% |
| FY2019 | $1.2B | +1.7% |
| FY2018 | $1.2B | +671.7% |
| FY2017 | $157.9M | -57.8% |
| FY2016 | $373.9M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice